Cassava Sciences Inc vs Omnicom Group Inc. — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Omnicom Group Inc. trades at $85.74 (market cap $23.58B). The key difference: Omnicom Group Inc. is far larger — about 493.8× Cassava Sciences Inc's market cap, and Omnicom Group Inc. pays a 3.72% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | OMC | |
|---|---|---|
Market Cap | $47.75M | $23.58B |
Sector | Health | Media |
52-Week High | $4.64 | $86.22 |
52-Week Low | $0.87 | $67.27 |
Enterprise Value | -$34.93M | $31.66B |
Dividend Yield | — | 3.72% |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →